Abat F, Alfredson H, Cucchiarini M, Madry H, Marmotti A, Mouton C, Oliveira J M, Pereira H, Peretti G M, Spang C, Stephen J, van Bergen C J A, de Girolamo L
Department of Sports Orthopaedics, ReSport Clinic, Passeig Fabra i Puig 47, 08030, Barcelona, Spain.
Sports Medicine Unit, University of Umeå, Umeå, Sweden.
J Exp Orthop. 2018 Sep 24;5(1):38. doi: 10.1186/s40634-018-0145-5.
The treatment of painful chronic tendinopathy is challenging. Multiple non-invasive and tendon-invasive methods are used. When traditional non-invasive treatments fail, the injections of platelet-rich plasma autologous blood or cortisone have become increasingly favored. However, there is little scientific evidence from human studies supporting injection treatment. As the last resort, intra- or peritendinous open or endoscopic surgery are employed even though these also show varying results. This ESSKA basic science committee current concepts review follows the first part on the biology, biomechanics and anatomy of tendinopathies, to provide a comprehensive overview of the latest treatment options for tendinopathy as reported in the literature.
疼痛性慢性肌腱病的治疗具有挑战性。人们采用了多种非侵入性和侵入肌腱的方法。当传统的非侵入性治疗失败时,富含血小板的血浆、自体血或皮质类固醇注射越来越受到青睐。然而,来自人体研究的科学证据很少支持注射治疗。作为最后的手段,即使这些手术的效果也各不相同,仍会采用肌腱内或肌腱周围的开放或内窥镜手术。ESSKA基础科学委员会的这份当前概念综述紧跟关于肌腱病的生物学、生物力学和解剖学的第一部分,以全面概述文献中报道的肌腱病最新治疗选择。